Home > Products > CD28 & CD44
> Anti-CD28 x Anti-CD44 Bispecific Antibody (IgG-IgG)
Anti-CD28 x Anti-CD44 Bispecific Antibody (IgG-IgG) (CAT#: BSIG-057)
Anti-CD28 x Anti-CD44 Bispecific Antibody (IgG-IgG) is designed to be generated by crosslinking two full length IgGs, anti-CD28 and anti-CD44 parental antibodies. A stable linkage is formed between the two antibodies. This BsAb can retarget T cells to tumor cells. It is designed for the research of Glioblastoma; Squamous cancer therapy.
There are currently no customer reviews or questions for Anti-CD28 x Anti-CD44 Bispecific Antibody (IgG-IgG) (BSIG-057). Click the button below to contact us or submit your feedback about this product.